Jack L Arbiser1, Michael Y Bonner2, Nicole Ward3, Justin Elsey4, Shikha Rao4. 1. Department of Dermatology, Emory University School of Medicine, Atlanta, GA 30322, USA; Veterans Affairs Medical Center, Decatur, GA 30322, USA. Electronic address: jarbise@emory.edu. 2. Department of Medical Biochemistry and Biophysics, Division of Medical Inflammation Research, Karolinska Institutet, Solna 171 65, Sweden. 3. Case Western Reserve University, Cleveland, OH0 44106, USA. 4. Department of Dermatology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Abstract
BACKGROUND: A link between selenium deficiency and inflammatory skin diseases have been noted by many, but this link is still not well understood. We have previously studied the efficacy of ceramide analogs, based on the fire ant venom Solenopsin A, against our psoriasis animal model. Treatment of animals with solenopsin analogs resulted in significantly improved skin as well as in a coordinate downregulation of selenoproteins, namely Glutathione Peroxidase 4 (GPX4). We thus hypothesize that ferroptosis may be a physiologic process that may protect the skin from both inflammatory and neoplastic processes. METHODS: We analyze and compare gene expression profiles in the GEO database from clinical skin samples taken from healthy patients and psoriasis patients (both involved and noninvolved skin lesions). We validated the gene expression results against a second, independent, cohort from the GEO database. RESULTS: Significant reduction in gene expression of GPX4, elevated expression of Nrf2 downstream targets, and expression profiles mirroring erastin-inhibition of Cystine/Glutamate Antiporter-System XC activity in psoriatic skin lesions, compared to both noninvolved skin and healthy patient samples, suggest an innately inducible mechanism of ferroptosis. CONCLUSIONS: We present data that may indicate selenoproteins, particularly GPX4, in resolving inflammation and skin cancer, including the novel hypothesis that the human organism may downregulate GPX4 and reactive oxygen (REDOX) regulating proteins in the skin as a way of resolving psoriasis and nonmelanoma skin cancer through increased reactive oxygen species. Further studies are needed to investigate ferroptosis as a possible physiologic mechanism for eliminating inflammatory and malignant tissues. GENERAL SIGNIFICANCE: This study provides a fresh framework for understanding the seemingly contradictory effects of selenium supplementation. In addition, it offers a novel explanation of how physiologic upregulation of ferroptosis and downregulation of selenoprotein synthesis may mediate resolution of inflammation and carcinogenesis. This is of therapeutic significance. Published by Elsevier B.V.
BACKGROUND: A link between seleniumdeficiency and inflammatory skin diseases have been noted by many, but this link is still not well understood. We have previously studied the efficacy of ceramide analogs, based on the fire ant venom Solenopsin A, against our psoriasis animal model. Treatment of animals with solenopsin analogs resulted in significantly improved skin as well as in a coordinate downregulation of selenoproteins, namely Glutathione Peroxidase 4 (GPX4). We thus hypothesize that ferroptosis may be a physiologic process that may protect the skin from both inflammatory and neoplastic processes. METHODS: We analyze and compare gene expression profiles in the GEO database from clinical skin samples taken from healthy patients and psoriasispatients (both involved and noninvolved skin lesions). We validated the gene expression results against a second, independent, cohort from the GEO database. RESULTS: Significant reduction in gene expression of GPX4, elevated expression of Nrf2 downstream targets, and expression profiles mirroring erastin-inhibition of Cystine/Glutamate Antiporter-System XC activity in psoriatic skin lesions, compared to both noninvolved skin and healthy patient samples, suggest an innately inducible mechanism of ferroptosis. CONCLUSIONS: We present data that may indicate selenoproteins, particularly GPX4, in resolving inflammation and skin cancer, including the novel hypothesis that the human organism may downregulate GPX4 and reactive oxygen (REDOX) regulating proteins in the skin as a way of resolving psoriasis and nonmelanoma skin cancer through increased reactive oxygen species. Further studies are needed to investigate ferroptosis as a possible physiologic mechanism for eliminating inflammatory and malignant tissues. GENERAL SIGNIFICANCE: This study provides a fresh framework for understanding the seemingly contradictory effects of selenium supplementation. In addition, it offers a novel explanation of how physiologic upregulation of ferroptosis and downregulation of selenoprotein synthesis may mediate resolution of inflammation and carcinogenesis. This is of therapeutic significance. Published by Elsevier B.V.
Authors: Ulrich Mühlenhoff; Sabine Molik; José R Godoy; Marta A Uzarska; Nadine Richter; Andreas Seubert; Yan Zhang; JoAnne Stubbe; Fabien Pierrel; Enrique Herrero; Christopher Horst Lillig; Roland Lill Journal: Cell Metab Date: 2010-10-06 Impact factor: 27.287
Authors: Peter M Elias; Jack Arbiser; Barbara E Brown; Heidemarie Rossiter; Mao-Qiang Man; Francesca Cerimele; Debra Crumrine; Roshan Gunathilake; Eung Ho Choi; Yoshikazu Uchida; Erwin Tschachler; Kenneth R Feingold Journal: Am J Pathol Date: 2008-08-07 Impact factor: 4.307
Authors: Rajan P Nair; Kristina Callis Duffin; Cynthia Helms; Jun Ding; Philip E Stuart; David Goldgar; Johann E Gudjonsson; Yun Li; Trilokraj Tejasvi; Bing-Jian Feng; Andreas Ruether; Stefan Schreiber; Michael Weichenthal; Dafna Gladman; Proton Rahman; Steven J Schrodi; Sampath Prahalad; Stephen L Guthery; Judith Fischer; Wilson Liao; Pui-Yan Kwok; Alan Menter; G Mark Lathrop; Carol A Wise; Ann B Begovich; John J Voorhees; James T Elder; Gerald G Krueger; Anne M Bowcock; Gonçalo R Abecasis Journal: Nat Genet Date: 2009-01-25 Impact factor: 38.330
Authors: Xiaoping Yang; Aliaa E M Daifallah; Shiela Shankar; Jacob Beer; Christine Marshall; Tzvete Dentchev; Francesca Seykora; Sebastian D'Armas; Jaeyi Hahn; Vivian Lee; Hanan H Sabry; Assem M Farag; John T Seykora Journal: Exp Dermatol Date: 2019-03-13 Impact factor: 3.960
Authors: Allen S W Oak; Rubina Shafi; Mahmoud Elsayed; Bharat Mishra; Sejong Bae; Stephen Barnes; Mahendra P Kashyap; Andrzej T Slominski; Landon S Wilson; Mohammad Athar; Craig A Elmets Journal: J Am Acad Dermatol Date: 2021-01-20 Impact factor: 11.527
Authors: Jie Li; Feng Cao; He-Liang Yin; Zi-Jian Huang; Zhi-Tao Lin; Ning Mao; Bei Sun; Gang Wang Journal: Cell Death Dis Date: 2020-02-03 Impact factor: 8.469